Provided by Tiger Trade Technology Pte. Ltd.

Avalo Therapeutics Inc

14.69
-0.2600-1.74%
Volume:312.18K
Turnover:4.57M
Market Cap:787.82M
PE:-3.33
High:15.16
Open:15.16
Low:14.31
Close:14.95
52wk High:24.27
52wk Low:12.41
Shares:53.63M
Float Shares:40.15M
Volume Ratio:0.48
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4100
EPS(LYR):-5.8400
ROE:-36.27%
ROA:-18.50%
PB:1.76
PE(LYR):-2.52

Loading ...

May 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 05, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 28, 2026

Major Issues Report

Form 8-K - Current report
Apr 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 27, 2026

Major Issues Report

Form 8-K - Current report
Mar 23, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 23, 2026

Major Issues Report

Form 8-K - Current report
Mar 23, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2026

Correspondence

Form CORRESP - Correspondence